Clinisys has announced the acquisition of Orchard Software from Francisco Partners, a leading global investment firm that specialises in partnering with technology businesses.
The acquisition brings together two leaders in the LIS market and reaffirms Clinisys’s continued commitment to provide the laboratory informatics marketplace with cutting edge software advancements.
The companies’ combined capabilities provide for comprehensive, flexible, and scalable informatics offerings that can better serve customers across the global diagnostics market.
“Joining forces with Clinisys marks a powerful new chapter for Orchard,” said Billie Whitehurst, Orchard’s CEO. “Our mission has always been to equip laboratorians with the tools they need to provide high-quality, efficient care. Clinisys shares that commitment and brings the global scale and innovation expertise needed to advance that mission even further.”
“We are excited to welcome Orchard to the Clinisys family,” said Michael Simpson, Clinisys’s CEO. “As a global leader in laboratory informatics, with over 45 years of domain experience, Clinisys has a clear strategy to create and deliver the next evolution of cloud-based laboratory solutions. As we continue to pursue excellence in developing both our world class solutions and our industry expertise, expanding with Orchard’s proven solution in the physician office, reference, and veterinary laboratory space was a clear decision for us. Together, we can better serve the entire spectrum of lab and diagnostic customers by enabling healthier and safer communities worldwide.”
Francisco Partners acquired Orchard Software in 2019 and since investing in the company, the firm has implemented a strategic transformation of the business, including modernising Orchard’s product suite, enhancing its cloud solutions, and strengthening its leadership team.
The combination of Orchard’s LIS portfolio and Clinisys’s LIMS and diagnostic solutions creates new opportunities for customers across North America and international markets.